Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study

Clinical trial NCT04768504 · TERMINATED

Trial details

NCT number: NCT04768504
Sponsor: Khashayar Esfahani
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune-Mediated Colitis

Start date: 2022-03-22
Primary completion: 2024-01-17
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.